Literature DB >> 16527442

Melatonin receptors in humans: biological role and clinical relevance.

C Ekmekcioglu1.   

Abstract

In addition to its antioxidative effects melatonin acts through specific nuclear and plasma membrane receptors. To date, two G-protein coupled melatonin membrane receptors, MT(1) and MT(2), have been cloned in mammals, while the newly purified MT(3) protein belongs to the family of quinone reductases. Screening studies have shown that various tissues of rodents express MT(1) and/or MT(2) melatonin receptors. In humans, melatonin receptors were also detected in several organs, including brain and retina, cardiovascular system, liver and gallbladder, intestine, kidney, immune cells, adipocytes, prostate and breast epithelial cells, ovary/granulosa cells, myometrium, and skin. This review summarizes the data published so far about MT(1) and MT(2) receptors in human tissues and human cells. Established and putative functions of melatonin after receptor activation as well as the clinical relevance of these findings will be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527442     DOI: 10.1016/j.biopha.2006.01.002

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  81 in total

1.  Effects of Kaixin Powder on melatonin receptor expression and (125)I-Mel binding affinity in a rat model of depression.

Authors:  Yan-li Huang; Xue-bing Liang; Li-qi Qian; Chuan Cai; Jun Guo; Chao Gao; Jian-hua Guan; Guo-ping Zhao
Journal:  Chin J Integr Med       Date:  2014-08-26       Impact factor: 1.978

Review 2.  Expression and putative functions of melatonin receptors in malignant cells and tissues.

Authors:  Cem Ekmekcioglu
Journal:  Wien Med Wochenschr       Date:  2014-07-15

3.  Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial.

Authors:  Marije Russcher; Birgit C P Koch; J Elsbeth Nagtegaal; Frans J van Ittersum; Pieternel C M Pasker-de Jong; E Chris Hagen; Wim Th van Dorp; Bas Gabreëls; Thierry X Wildbergh; Monique M L van der Westerlaken; Carlo A J M Gaillard; Piet M Ter Wee
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

4.  MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans.

Authors:  Ehm A Andersson; Birgitte Holst; Thomas Sparsø; Niels Grarup; Karina Banasik; Johan Holmkvist; Torben Jørgensen; Knut Borch-Johnsen; Kristoffer L Egerod; Torsten Lauritzen; Thorkild I A Sørensen; Amélie Bonnefond; David Meyre; Philippe Froguel; Thue W Schwartz; Oluf Pedersen; Torben Hansen
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

5.  Melatonin improves memory acquisition under stress independent of stress hormone release.

Authors:  Ulrike Rimmele; Maria Spillmann; Carmen Bärtschi; Oliver T Wolf; Cora S Weber; Ulrike Ehlert; Petra H Wirtz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

6.  Modulation of Diabetes-Induced Oxidative Stress, Apoptosis, and Ca2+ Entry Through TRPM2 and TRPV1 Channels in Dorsal Root Ganglion and Hippocampus of Diabetic Rats by Melatonin and Selenium.

Authors:  Mehmet Cemal Kahya; Mustafa Nazıroğlu; İshak Suat Övey
Journal:  Mol Neurobiol       Date:  2016-03-09       Impact factor: 5.590

Review 7.  Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation.

Authors:  James E Fildes; Nizar Yonan; Brian G Keevil
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

8.  Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy.

Authors:  Mustafa Nazıroglu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

9.  MT1 melatonin receptor expression in Warthin's tumor.

Authors:  Jose Aneiros-Fernandez; Salvador Arias-Santiago; Borja Arias-Santiago; Maria Herrero-Fernández; V Carriel; Jose Aneiros-Cachaza; Antonio López-Valverde; Antonio Cutando-Soriano
Journal:  Pathol Oncol Res       Date:  2012-10-17       Impact factor: 3.201

10.  Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.

Authors:  Richard Rosen; Dan-Ning Hu; Violete Perez; Katy Tai; Guo-Pei Yu; Min Chen; Paul Tone; Steven A McCormick; Joseph Walsh
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.